Auckland Waikato Tauranga

Headshot of a man with short hair, glasses, and a smile, wearing a striped shirt and black blazer.

Dr James Fulforth

I was born and brought up in the UK and studied medicine in Edinburgh before moving to New Zealand in 2008. I completed gastroenterology training in 2017 following spells in Waikato and Christchurch. I then undertook an advanced fellowship at the Edinburgh IBD unit, where I cared for complex patients with inflammatory bowel disease as part of a highly specialised unit, performed a high volume of endoscopy and took part in further research in this area. I have been a consultant at Waikato Hospital since 2019 where I care for patients with a broad range of GI disease and continue to pursue these research interests.

After multiple international moves over the years, my family and I are excited to have made the Waikato home, and I am passionate about providing outstanding gastroenterology services for our local community.

Area of expertise:

  • Accredited National Bowel Cancer Screening Endoscopist
  • Diagnostic & Therapeutic Endoscopy (including chromoendoscopy)
  • Inflammatory Bowel Disease (Crohn’s disease & ulcerative colitis)
  • Irritable Bowel Syndrome
  • Dyspepsia
  • Coeliac disease
  • Gastrointestinal cancer
  • Oesophageal manometry and pH studies
  • Gastrointestinal bleeding
  • Liver disease

Current Employment

Consultant Gastroenterologist & Endoscopy Training Lead, Waikato DHB

Qualifications

  • FRACP (2017)
  • MBChB (2006)
  • BSc Med Sci (Hons) (2003)

Training

  • Advanced Gastroenterology Fellowship, The Edinburgh IBD Unit, Western General Hospital, Edinburgh (2018-2019)
  • Advanced Training in Gastroenterology at Waikato & Christchurch Hospitals (2014-2017)
  • Basic Physician Training in Wellington & Melbourne (2010-2014)

Research

  • James Fulforth & Richard Gearry on behalf of The CCNZ #wecan’twait committee. Inequitable Access to IBD Therapies Extends Beyond Developing Nations. Journal of Crohn’s & Colitis (2022).
  • Mathew Lyons, Lauranne Derikx, James Fulforth et al. Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland; a retrospective prevalent cohort analysis. Alimentary Pharmacology & Therapeutics (2022)
  • N Plevris, J Fulforth, S Siakavellas et al. Real-world effectiveness and safety of ustekinumab for the treatment of Crohn’s disease: The Scottish ustekinumab cohort. Journal of Gastroenterology & Hepatology (2020)

Memberships

  • Fellow of the Royal Australasian College of Physicians
  • New Zealand Society of Gastroenterology
  • European Crohn’s & Colitis Organisation

    Contact us